X

Dangers of the High-Sodium Diet

By: Anjali Rana PharmD. Candidate c/o 2025              While too much of any food or substance is not good, sodium-rich…

eMAR

NMOSD Treatment

By: Lyana Sayilar PharmD. Candidate c/o 2022              Neuromyelitis optica spectrum disorder (NMOSD) is a rare disorder affecting 4,000 to…

eMAR

FDA Approves GlaxoSmithKline’s Combined Formulation of Ibuprofen-Acetaminophen: Is This a Step in the Direction of Increased Patient Adherence in Pain Relief and the Fight Against the Opioid Epidemic?

By: Edwin Gruda, PharmD Candidate c/o 2022; Aiśa Mrkulic, PharmD. Candidate c/o 2022              Over-the-Counter (OTC) medications are typically used…

eMAR

EndeavourRx ™: The Prescription-Only, FDA-Approved Videogame for Children with ADHD

By: Aiśa Mrkulic PharmD Candidate c/o 2022              Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common reasons…

eMAR

Daniel Schneider RPh.’s crusade against OxyContin

By: Alisha Kuriakose, PharmD Candidate c/o 2022 “The Pharmacist” is a Netflix documentary that showcases pharmacist Dr. Daniel Schneider’s crusade…

eMAR

Next Up in the World of Hyperlipidemia: Nexletlol TM

By: Preethi Samuel, Pharm.D. Candidate c/o of 2021              In the United States, at least one person has a heart…

eMAR

Antibiotic Resistance: Why It’s Important to Educate the Future Generation & What I Learned from Doing So

By: Natalia Jucha PharmD Candidate c/o 2022              Due to the overuse and misuse of these medications, antibiotics are no…

eMAR

Vancomycin Monitoring for Serious MRSA Infections in Adults

By: Darien Lee, Pharm D Candidate c/o 2021              Vancomycin, a glycopeptide antibiotic, is one of the most commonly used…

eMAR

Transition of Care: A New and Emerging Pharmacy Specialty

By: Sami Barakat, PharmD. and Natalia Jucha, PharmD. Candidate c/o 2022              Since the publication of the Institute of Medicine…

eMAR

MIS-C: The Impact of COVID-19 on the Pediatric Population

By: Erica Tonti, PharmD Candidate c/o 2022 Multisystem Inflammatory Syndrome in Children, or MIS-C, is a recent syndrome recognized by…

eMAR